Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials

Consensus Recommendations and Further Research Priorities

The Stroke Imaging Research (STIR) and VISTA-Imaging Investigators

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background and Purpose - The Stroke Imaging Research (STIR) group, the Imaging Working Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology sponsored an imaging session and workshop during the Stroke Treatment Academy Industry Roundtable (STAIR) IX on October 5 to 6, 2015 in Washington, DC. The purpose of this roadmap was to focus on the role of imaging in future research and clinical trials. Methods - This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), industry representatives, and members of the US Food and Drug Administration to discuss STIR priorities in the light of an unprecedented series of positive acute stroke endovascular therapy clinical trials. Results - The imaging session summarized and compared the imaging components of the recent positive endovascular trials and proposed opportunities for pooled analyses. The imaging workshop developed consensus recommendations for optimal imaging methods for the acquisition and analysis of core, mismatch, and collaterals across multiple modalities, and also a standardized approach for measuring the final infarct volume in prospective clinical trials. Conclusions - Recent positive acute stroke endovascular clinical trials have demonstrated the added value of neurovascular imaging. The optimal imaging profile for endovascular treatment includes large vessel occlusion, smaller core, good collaterals, and large penumbra. However, equivalent definitions for the imaging profile parameters across modalities are needed, and a standardization effort is warranted, potentially leveraging the pooled data resulting from the recent positive endovascular trials.

Original languageEnglish (US)
Pages (from-to)1389-1398
Number of pages10
JournalStroke
Volume47
Issue number5
DOIs
StatePublished - May 1 2016

Fingerprint

Reperfusion
Stroke
Clinical Trials
Research
Industry
Consensus Development Conferences
National Institute of Neurological Disorders and Stroke
United States Food and Drug Administration
Neuroimaging
Therapeutics
Education

All Science Journal Classification (ASJC) codes

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials : Consensus Recommendations and Further Research Priorities. / The Stroke Imaging Research (STIR) and VISTA-Imaging Investigators.

In: Stroke, Vol. 47, No. 5, 01.05.2016, p. 1389-1398.

Research output: Contribution to journalArticle

@article{df69200621b84e8d98b9dc4c099207c3,
title = "Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials: Consensus Recommendations and Further Research Priorities",
abstract = "Background and Purpose - The Stroke Imaging Research (STIR) group, the Imaging Working Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology sponsored an imaging session and workshop during the Stroke Treatment Academy Industry Roundtable (STAIR) IX on October 5 to 6, 2015 in Washington, DC. The purpose of this roadmap was to focus on the role of imaging in future research and clinical trials. Methods - This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), industry representatives, and members of the US Food and Drug Administration to discuss STIR priorities in the light of an unprecedented series of positive acute stroke endovascular therapy clinical trials. Results - The imaging session summarized and compared the imaging components of the recent positive endovascular trials and proposed opportunities for pooled analyses. The imaging workshop developed consensus recommendations for optimal imaging methods for the acquisition and analysis of core, mismatch, and collaterals across multiple modalities, and also a standardized approach for measuring the final infarct volume in prospective clinical trials. Conclusions - Recent positive acute stroke endovascular clinical trials have demonstrated the added value of neurovascular imaging. The optimal imaging profile for endovascular treatment includes large vessel occlusion, smaller core, good collaterals, and large penumbra. However, equivalent definitions for the imaging profile parameters across modalities are needed, and a standardization effort is warranted, potentially leveraging the pooled data resulting from the recent positive endovascular trials.",
author = "{The Stroke Imaging Research (STIR) and VISTA-Imaging Investigators} and Warach, {Steven J.} and Marie Luby and Albers, {Gregory W.} and Roland Bammer and Andrew Bivard and Campbell, {Bruce C.V.} and Colin Derdeyn and Heit, {Jeremy J.} and Pooja Khatri and Lansberg, {Maarten G.} and Liebeskind, {David S.} and Majoie, {Charles B.L.M.} and Marks, {Michael P.} and Menon, {Bijoy K.} and Muir, {Keith W.} and Parsons, {Mark W.} and Achala Vagal and Yoo, {Albert J.} and Alexandrov, {Andrei V.} and Baron, {Jean Claude} and Andrei Alexandrov and Furlan, {Anthony J.} and Josep Puig and Schellinger, {Peter D.} and Max Wintermark",
year = "2016",
month = "5",
day = "1",
doi = "10.1161/STROKEAHA.115.012364",
language = "English (US)",
volume = "47",
pages = "1389--1398",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials

T2 - Consensus Recommendations and Further Research Priorities

AU - The Stroke Imaging Research (STIR) and VISTA-Imaging Investigators

AU - Warach, Steven J.

AU - Luby, Marie

AU - Albers, Gregory W.

AU - Bammer, Roland

AU - Bivard, Andrew

AU - Campbell, Bruce C.V.

AU - Derdeyn, Colin

AU - Heit, Jeremy J.

AU - Khatri, Pooja

AU - Lansberg, Maarten G.

AU - Liebeskind, David S.

AU - Majoie, Charles B.L.M.

AU - Marks, Michael P.

AU - Menon, Bijoy K.

AU - Muir, Keith W.

AU - Parsons, Mark W.

AU - Vagal, Achala

AU - Yoo, Albert J.

AU - Alexandrov, Andrei V.

AU - Baron, Jean Claude

AU - Alexandrov, Andrei

AU - Furlan, Anthony J.

AU - Puig, Josep

AU - Schellinger, Peter D.

AU - Wintermark, Max

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Background and Purpose - The Stroke Imaging Research (STIR) group, the Imaging Working Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology sponsored an imaging session and workshop during the Stroke Treatment Academy Industry Roundtable (STAIR) IX on October 5 to 6, 2015 in Washington, DC. The purpose of this roadmap was to focus on the role of imaging in future research and clinical trials. Methods - This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), industry representatives, and members of the US Food and Drug Administration to discuss STIR priorities in the light of an unprecedented series of positive acute stroke endovascular therapy clinical trials. Results - The imaging session summarized and compared the imaging components of the recent positive endovascular trials and proposed opportunities for pooled analyses. The imaging workshop developed consensus recommendations for optimal imaging methods for the acquisition and analysis of core, mismatch, and collaterals across multiple modalities, and also a standardized approach for measuring the final infarct volume in prospective clinical trials. Conclusions - Recent positive acute stroke endovascular clinical trials have demonstrated the added value of neurovascular imaging. The optimal imaging profile for endovascular treatment includes large vessel occlusion, smaller core, good collaterals, and large penumbra. However, equivalent definitions for the imaging profile parameters across modalities are needed, and a standardization effort is warranted, potentially leveraging the pooled data resulting from the recent positive endovascular trials.

AB - Background and Purpose - The Stroke Imaging Research (STIR) group, the Imaging Working Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology sponsored an imaging session and workshop during the Stroke Treatment Academy Industry Roundtable (STAIR) IX on October 5 to 6, 2015 in Washington, DC. The purpose of this roadmap was to focus on the role of imaging in future research and clinical trials. Methods - This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), industry representatives, and members of the US Food and Drug Administration to discuss STIR priorities in the light of an unprecedented series of positive acute stroke endovascular therapy clinical trials. Results - The imaging session summarized and compared the imaging components of the recent positive endovascular trials and proposed opportunities for pooled analyses. The imaging workshop developed consensus recommendations for optimal imaging methods for the acquisition and analysis of core, mismatch, and collaterals across multiple modalities, and also a standardized approach for measuring the final infarct volume in prospective clinical trials. Conclusions - Recent positive acute stroke endovascular clinical trials have demonstrated the added value of neurovascular imaging. The optimal imaging profile for endovascular treatment includes large vessel occlusion, smaller core, good collaterals, and large penumbra. However, equivalent definitions for the imaging profile parameters across modalities are needed, and a standardization effort is warranted, potentially leveraging the pooled data resulting from the recent positive endovascular trials.

UR - http://www.scopus.com/inward/record.url?scp=84964889116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964889116&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.115.012364

DO - 10.1161/STROKEAHA.115.012364

M3 - Article

VL - 47

SP - 1389

EP - 1398

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 5

ER -